Your browser doesn't support javascript.
loading
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection.
Curlin, Marcel E; Bates, Timothy A; Guzman, Gaelen; Schoen, Devin; McBride, Savannah K; Carpenter, Samuel D; Tafesse, Fikadu G.
Afiliación
  • Curlin ME; Department of Medicine, Division of Infectious Diseases, Oregon Health & Science University, Portland, OR 97239, USA. Electronic address: curlin@ohsu.edu.
  • Bates TA; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA.
  • Guzman G; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA.
  • Schoen D; Department of Medicine, Division of Infectious Diseases, Oregon Health & Science University, Portland, OR 97239, USA.
  • McBride SK; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA.
  • Carpenter SD; Department of Psychiatry, Oregon Health & Science University, Portland, OR 97239, USA.
  • Tafesse FG; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA. Electronic address: tafesse@ohsu.edu.
Med ; 3(12): 827-837.e3, 2022 Dec 09.
Article en En | MEDLINE | ID: mdl-36198311

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Límite: Adult / Humans Idioma: En Revista: Med Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Límite: Adult / Humans Idioma: En Revista: Med Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos